During the past decade, Centro Privado de Medicina Familiar conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Privado de Medicina Familiar" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro Privado de Medicina Familiar" are "Systemic Lupus Erythematosus" (2 trials), "Arthritis" (1 trials), "Arthritis, Psoriatic" (1 trials), "Autoimmune Diseases" (1 trials) and "Connective Tissue Diseases" (1 trials). Many other conditions were trialed in "Centro Privado de Medicina Familiar" in a lesser frequency.

Most popular intervention types in "Centro Privado de Medicina Familiar" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Belimumab 1 mg/kg" (1 trials), "Belimumab 10 mg/kg" (1 trials), "Guselkumab" (1 trials) and "Nipocalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Privado de Medicina Familiar" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Centro Privado de Medicina Familiar". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Privado de Medicina Familiar, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Privado de Medicina Familiar, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".